T_NN
cells_NNS
from_IN
renal_JJ
cell_NN
carcinoma_NN
patients_NNS
exhibit_VBP
an_DT
abnormal_JJ
pattern_NN
of_IN
kappa_NN
B-specific_JJ
DNA-binding_JJ
activity_NN
:_:
a_DT
preliminary_JJ
report_NN
._.

Recent_JJ
data_NNS
suggest_VBP
that_IN
the_DT
poor_JJ
induction_NN
of_IN
a_DT
T-cell_NN
response_NN
to_TO
human_JJ
renal_JJ
cell_NN
carcinoma_NN
-LRB-_-LRB-
RCC_NN
-RRB-_-RRB-
may_MD
be_VB
related_JJ
to_TO
alterations_NNS
in_IN
signal_NN
transduction_NN
pathways_NNS
._.

We_PRP
report_VBP
that_IN
T_NN
cells_NNS
from_IN
RCC_NN
patients_NNS
have_VBP
two_CD
alterations_NNS
in_IN
kappa_NN
B_NN
motif-specific_JJ
DNA-binding_JJ
activity_NN
._.

The_DT
first_JJ
alteration_NN
involves_VBZ
the_DT
constitutive_JJ
expression_NN
of_IN
substantial_JJ
kappa_NN
B-binding_JJ
activity_NN
in_IN
nuclear_JJ
extracts_NNS
,_,
which_WDT
was_VBD
observed_VBN
in_IN
the_DT
electrophoretic_JJ
mobility_NN
shift_NN
assay_NN
._.

The_DT
magnitude_NN
of_IN
kappa_NN
B_NN
activity_NN
in_IN
unstimulated_JJ
patient_NN
T_NN
cells_NNS
was_VBD
similar_JJ
to_TO
that_DT
observed_VBN
in_IN
T_NN
cells_NNS
from_IN
normal_JJ
individuals_NNS
that_WDT
had_VBD
been_VBN
activated_VBN
in_FW
vitro_FW
._.

On_IN
the_DT
basis_NN
of_IN
Western_NN
blotting_NN
experiments_NNS
using_VBG
antibodies_NNS
to_TO
kappa_NN
B\/Rel_NN
family_NN
proteins_NNS
,_,
the_DT
kappa_NN
B-binding_JJ
activity_NN
constitutively_RB
expressed_VBN
in_IN
T_NN
cells_NNS
from_IN
RCC_NN
patients_NNS
is_VBZ
composed_VBN
mostly_RB
of_IN
the_DT
NF-kappa_NN
B1_NN
-LRB-_-LRB-
p50_NN
-RRB-_-RRB-
subunit_NN
._.

The_DT
second_JJ
abnormality_NN
in_IN
kappa_NN
B-binding_JJ
activity_NN
in_IN
T_NN
cells_NNS
from_IN
these_DT
patients_NNS
is_VBZ
that_IN
RelA_NN
,_,
a_DT
member_NN
of_IN
the_DT
Rel_NN
homology_NN
family_NN
which_WDT
is_VBZ
part_NN
of_IN
the_DT
normal_JJ
NF-kappa_NN
B_NN
complex_NN
,_,
was_VBD
not_RB
induced_VBN
in_IN
the_DT
nucleus_NN
following_VBG
activation_NN
._.

Western_NN
blotting_NN
analysis_NN
did_VBD
not_RB
detect_VB
any_DT
RelA_NN
in_IN
nuclear_JJ
extracts_NNS
either_CC
before_IN
or_CC
after_IN
stimulation_NN
of_IN
T_NN
cells_NNS
._.

The_DT
altered_JJ
kappa_NN
B-binding_JJ
activity_NN
in_IN
T_NN
cells_NNS
from_IN
RCC_NN
patients_NNS
may_MD
impair_VB
their_PRP$
capacity_NN
to_TO
respond_VB
normally_RB
to_TO
various_JJ
stimuli_NNS
._.

